Selected Publications
1. Wei N, Zhu LQ, Liu D. ATF4: a Novel Potential Therapeutic Target for Alzheimer's Disease. MolNeurobiol. 2015 Dec;52(3):1765-70.
2. Xiong YS#, Liu FF#, Liu D, Huang HZ, Wei N, Tan L, Chen JG, Man HY, Gong CX, Lu Y, Wang JZ*, Zhu LQ*. Opposite effects of two estrogen receptors on tau phosphorylation through disparate effects on the miR-218/PTPA pathway.Aging Cell. 2015 Oct;14(5):867-77.
3. Liu D, Wei N, Man HY, Lu Y*, Zhu LQ*, Wang JZ*. The MT2 receptor stimulates axonogenesis and enhances synaptic transmission by activating Akt signaling. Cell Death Differ. 2015 Apr;22(4):583-96.
4. Chen Y#, Wang B#, Liu D, Li JJ, Xue Y, Sakata K, Zhu LQ, Heldt SA, Xu H, Liao FF. Hsp90 chaperone inhibitor 17-AAG attenuates Aβ-induced synaptic toxicity and memory impairment. J Neurosci. 2014 Feb 12;34(7):2464-70.
5. Wang X, Wang LP, Tang H, Shan WY, Wang X, Liu D*, Wu YY, Tian Q, Wang JZ*, Zhu LQ*. Acetyl-l-carnitine rescues scopolamine-induced memory deficits by restoring insulin-like growth factor II via decreasing p53 oxidation. Neuropharmacology. 2014 Jan;76Pt A:80-7.
6. Tang H#, Shen N#, Jin H#, Liu D*, Miao X*, Zhu LQ*. GSK-3β Polymorphism Discriminates Bipolar Disorder and Schizophrenia: A Systematic Meta-Analysis. MolNeurobiol. 2013 Dec;48(3):404-11.
7. Tan L, Wang X, Ni ZF, Zhu X, Wu W, Zhu LQ, Liu D. A Systematic Analysis of Genomic Changes in Tg2576 Mice.MolNeurobiol. 2013 Jun;47(3):883-91.
8. Wang X#, Wang ZH#, Wu YY, Tang H, Tan L, Wang X, Gao XY, Xiong YS, Liu D*, Wang JZ, Zhu LQ*. Melatonin attenuates scopolamine-induced memory/synaptic disorder by rescuing EPACs/miR-124/Egr1 pathway. MolNeurobiol. 2013 Feb;47(1):373-81.
9. Peng CX#, Hu J#, Liu D, Hong XP, Wu YY, Zhu LQ*, Wang JZ*. Disease-modified glycogen synthase kinase-3β intervention by melatonin arrests the pathology and memory deficits in an Alzheimer's animal model. Neurobiol Aging. 2013 Jun;34(6):1555-63.
10. Wu YY, Wang X, Tan L, Liu D, Liu XH, Wang Q, Wang JZ*, Zhu LQ*. Lithium attenuates scopolamine-induced memory deficits with inhibition of GSK-3β and preservation of postsynaptic components. J Alzheimers Dis. 2013;37(3):515-27.
11. Wang SH#, Liao XM#, Liu D, Hu J, Yin YY, Wang JZ*, Zhu LQ*. NGF promotes long-term memory formation by activating poly(ADP-ribose)polymerase-1. Neuropharmacology. 2012 Nov;63(6):1085-92.
12. Yang Y#, Shu X#, Liu D#, Shang Y, Wu Y, Pei L, Xu X, Tian Q, Zhang J, Qian K, Wang YX, Petralia RS, Tu WH, Zhu LQ*, Wang JZ*, Lu Y*. EPAC Null Mutation Impairs Learning and Social Interactions via Aberrant Regulation of miR-124 and Zif268 Translation.Neuron. 2012 Feb 23;73(4):774-88.
13. Liu D, Zheng HY, Luo ZZ, Wang Q, Zhu LQ. Effect of PP-2A on neurite outgrowth in neuronal cells. In Vitro Cell Dev-AN. 2010 Sep;46(8):702-7.
14. Zhu LQ#, Liu D#, Hu J, Cheng J, Wang SH, Wang Q, Wang F, Chen JG, Wang JZ. GSK-3b inhibits presynaptic vesicle exocytosis by phosphorylating P/Q-type calcium channel and interrupting SNARE complex formation. J Neurosci. 2010 Mar 10;30(10):3624-33.
15. Zhu LQ#, Zheng HY#, Peng CX, Liu D, Li HL, Wang Q, Wang JZ. Protein phosphatase 2A facilitates functional axonogenesis by dephosphorylating CRMP2. J Neurosci. 2010 Mar 10;30(10):3839-48.
16. Zhu LQ#, Wang SH#, Liu D, Yin YY, Tian Q, Wang XC, Wang Q, Chen JG, Wang JZ. Activation of glycogen synthase kinase-3 inhibits long term potentiation with synapse-associated impairments. J Neurosci. 2007 Nov 7;27(45):12211-20.